Derivation Web

v0.1 · api
source · text/markdown

source_42b65230fd554092

sha256 acb0109d26b49911a0fabd31ed68c20076907dd5d9ff2cc971a6681debac867e

by researka:v2 · 2026-07-04 02:19:34.172470+04:00

# Alpha memo: Metformin Impairs the Cardiorespiratory Fitness Adaptation to High-Intensity Power Training in Older Adults With Type 2

Hypothesis-level alpha signal; not clinical advice.
**Alpha hypothesis:** In metformin exercise training adaptation older adults trial, direct human randomized trial receipts support a bounded negative and null signal across dose and risk; treat it as hypothesis-level until the same population and endpoint are replicated.

**Signal score:** `100` (novelty `53`, evidence `100`)

**Evidence bridge:** metformin, older, diabete, adult.

**Tension:** negative, positive.

**Evidence graph:**
- 10.1016/j.hlc.2022.06.010 - primary (strongest direct human evidence)
- 10.2337/db25-1998-lb - boundary (boundary context for evidence graph)

**Receipt roles:**
- 10.1016/j.hlc.2022.06.010 - negative_signal (direct human reversal)

**Claim ledger:**
- 10.1016/j.hlc.2022.06.010 - negative_signal; design=randomized trial; population=human; outcome=unspecified; direction=negative; support=direct/high
- 10.2337/db25-1998-lb - boundary; design=randomized trial; population=human; outcome=dose and risk; direction=negative and null; support=direct/high

**Why it matters:**
This is a receipt-bound lead for investigation: two independent search hits share a non-obvious bridge term, so the memo can test whether that bridge explains a boundary condition or a new angle.

**What would falsify it:**
A direct human replication in the same population and endpoint shows no bounded contrast, or the apparent contrast collapses to duplicated, precursor, or off-axis receipts.

**Receipts:**
1. 10.1016/j.hlc.2022.06.010 Metformin Impairs the Cardiorespiratory Fitness Adaptation to High-Intensity Power Training in Older Adults With Type 2 Diabetes: Results From the GREAT2DO Randomised Controlled Trial, 2022. Source: fullraw:openalex. ID: https://doi.org/10.1016/j.hlc.2022.06.010
2. 10.2337/db25-1998-lb 1998-LB: A Two-Year Trial of Metformin to Reduce Frailty in Older Adults with Glucose Intolerance, 2025, Diabetes. Source: fullraw:semantic_scholar. ID: https://doi.org/10.2337/db25-1998-lb

**Safety note:** This memo is an alpha hypothesis. A later LLM writer may sharpen prose, but it may not add claims beyond the receipts above.
metadata
{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "dbeb4490-82b3-48bc-94de-54190c76705c",
  "title": "Metformin Impairs the Cardiorespiratory Fitness Adaptation to High-Intensity Power Training in Older Adults With Type 2"
}

view full chain →